newsfilter
← Latest News
GlobeNewswire·

Complete Response Letter Received from FDA for Treosulfan

TORONTO and CHICAGO and WEDEL, Germany, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. ("Medexus" or the "Company") (TSX:MDP) (OTCQX:MEDXF) and medac GmbH ("medac") announced today that medac, Medexus' licensor for treosulfan, has recei